Validity of 6 Minutes Stepper Test in Hypertension

Validity and Reliability of 6 Minutes Stepper Test in Hypertensive Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06087172

Enrollment

Registered

2023-10-17

Start date

2022-06-01

Completion date

2022-12-01

Last updated

2023-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arterial Hypertension, Hypertension

Keywords

Stepper Test, Exercise Capacity, Cardiac Rehabilitation

Brief summary

The six minutes stepper test (6MST) was used assess exercise capacity of individuals having different chronic conditions. In the literature, there are some validation studies analyzing validity of 6MST. In this study, the main aim was to analyse validation of 6MST in hypertensive individuals.

Detailed description

6MST is a space-safe, feasible and sensitive test to assess exercise capacity. In the literature, there are lots of field tests assessing exercise capacity of individuals with chronic status. But common field tests eg 6MWT requires long spaces and it could become an important barrier in clinical settings. Hypertension is a common chronic disease and hypertensive individuals are important candidates of cardiac rehabilitation. As an important outcome assesing exercise capacity are very important before and after cardiac rehabilitation. In this study, the main aim was to investigate reliability and validity of 6MST in systemic hypertension.

Interventions

DIAGNOSTIC_TESTSix Minutes Stepper Test (6MST)

Patients were applied two 6MST and 6MWT. 6MWT was conducted to test convergent validity of 6MST.

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Inclusion criteria

s: * Being 18 to 65 years, * Diagnosed with hypertension and willing to participate the study.

Exclusion criteria

s: * having a neurological, cognitive and/or orthopedic disease that affect the measurements, * severe respiratory disease (FEV1 \< 35%; FVC \< 50%), * presence of acute infection, * any malignancy, * dementia, * any cardiovascular event in the last 6 months, * uncontrolled hypertension and diabetes * body mass index (BMI) higher than 40 kg/m2

Design outcomes

Primary

Measure	Time frame	Description
exercise capacity	through study completion two day	steps during 6MST
functional capacity	through study completion two day	walking distance during 6MWT

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026